U.S. Environmental Protection Agency 8/18/ 2010

Hexabromocyclododecane (HBCD)

Action Plan

I. Overview

HBCD is a brominated flame retardant found world-wide in the environment and wildlife. Human exposure is evidenced from its presence in breast milk, adipose tissue and blood. It bioaccumulates and biomagnifies in the food chain. It persists and is transported long distances in the environment, and highly toxic to aquatic organisms. It also presents potential

human health concerns based on animal test results indicating pot ential reproductive, developmental and neurological effects. Fo r these reasons, the E nvironmental Protection Agency (EPA) intends to consider initiating ac tion under the Toxic Substances Control Act to address the manufacturing, pr ocessing, distribution in comme rce, and use of HBCD.

As part of the Agency's efforts to addre ss HBCD, EPA also intends to evaluate the potential for disproportionate impact on children and other sub-populations.

II. Introduction

As part of EPA’s efforts to enhance th e existing chemicals program under the Toxic Substances Control Act (TSCA) 1 , the Agency has identified certain widely recognized chemicals, including HBCD, for action plan deve lopment based on their presence in humans; persistent, bioaccumulative, and toxic (PBT) 2 characteristics; use in consumer products; production volume; or other similar factors. This Action Plan is based on EP A’s initial review of readily available use, exposure, and hazard information on HBCD. EPA considered which of the various authorities provided under TSCA and othe r statutes might be a ppropriate to address potential concerns with HBCD in developing the Action Plan. The Action Plan is intended to describe the courses of action the Agency plan s to pursue in the near term to address its

concerns. The Action Plan does not constitute a final Agency determination or other final Agency action. Regulatory proceedings indicate d by the Action Plan wi ll include appropriate opportunities for public and stakeholder i nput, including through notice and comment rulemaking processes.

III. Scope of Review

HBCD is a category of brominated flame retard ants, consisting of 16 possible isomers. It

has a molecular formula of C 12 H 18 Br 6 and its structure consists of a ring of 12 carbon atoms to which 18 hydrogen and six bromine atoms are bound. Hexabromocyclododecane may be designated as a non-specific mixture of all isomers (Hexabromocyclododecane; CASRN 25637- 99-4) or as a mixture of three main diastereomers (1,2,5,6,9,10-hexabromocyclododecane;

CASRN 3194-55-6. Both CASRNs ar e listed on the TSCA Inventory. Commercial preparations of HBCD may contain some possible impurities, such as tetrabromocyclododecene or other.

1 15 U.S.C. §2601 et seq.
2 Information on PBT chemicals can be found on the EPA website at: http://www.epa.gov/oppt/newchems/pubs/pbtpolcy.htmisomeric HBCDs (UNEP, 2009). All isomers of HBCD are the subject of this Action Plan, irrespective of the particular CASR N or name used to identify them 3

.

IV. Uses and Substitutes Summary

Uses

HBCD, with an 8% share in the brominated flame retardant (BFR) global market in 2001, is the third most commonly used BFR, following tetrabromobisphenol A (TBBPA; approximately 59% of the market), and decabrom odiphenyl ether (deca-BDE; 26% market share) (Morose, 2006).

The main use of HBCD is as a flame retard ant in expanded polyst yrene foam (EPS) and extruded polystyrene foam (XPS) (Weil and Le vchik, 2009). EPS and XPS are used primarily for thermal insulation boards in the building a nd construction industry (M orose, 2006). HBCD is used because it is highly effective at low c oncentrations; EPS boards contain approximately 0.5% HBCD by weight in the fi nal product (Morose, 2006).

HBCD may also be used as a flame retard ant in the backcoating of textiles for upholstered furniture, upholstery se ating in transportation vehicl es, draperies, wall coverings, mattress ticking, and inte rior textiles such as roller blinds (Morose, 2006; ECHA, 2009). The

maximum concentration of CASRN 3194-55-6 for us e in fabrics and textiles and in rubber and plastic products ranges from 1-30% (US EPA, 2006). The majority of HBCD used in textiles is for upholstered furniture, in order to meet the st ringent fire safety la ws of the United Kingdom and California (Morose, 2006). However, accord ing to the 2006 TSCA Inventory Update Rule (IUR) data (which includes information for ch emicals manufactured and imported in amounts of 25,000 pounds or greater at a single site), less than 1% of the total commercial and consumer use of HBCD was used for fabrics, tex tiles and apparel (US EPA, 2006).

In addition, HBCD is used as a flame retard ant in high impact polystyrene (HIPS) for

electrical and electronic appliances such as audio-visual equipment, and some wire and cable applications (Morose, 2006 and ECHA, 2009). Less than 10% of all HBCD used in Europe is used in HIPS (ECHA, 2009).

Production

The annual United States (U.S.) impor t/production volume of CASRN 25637-99-4 was between 10,000 and 500,000 pounds as reported to EPA in 2002; no import/production was reported in 2006 (US EPA, 2006). The annual U.S. import/production volume of CASRN 3194- 55-6 was 10-50 million pounds reported in 2002 and 2006 (US EPA, 2006). The U.S. International Trade Commission reporte d that 380,000 pounds of HBCD (1,3,5,7,9,11-HBCD isomer) were imported in 2008 (US ITC, 2010). In 2006, five facilities reported either the manufacture or importation of at least 25,000 pounds of HBCD: Albemarle (2 facilities), BASF, LG Chem America and Chemtura (US EPA, 2006).

3 For example, The U.S. International Trade Commission December 2009 Publication 4121 reports importation of the 1,3,5,7,9,11-HBCD isomer which would be subject to this action plan.

Page 2 of 12Substitutes

According to the European Chemicals Agency (ECHA) there are currently no commercially or technically viable alternatives for HBCD as a flame retardant in polystyrene foam, as all alternative flame retardants it note d impair the structure and properties of the foam, making it unsuitable for use (ECHA, 2009). Some commercially available brominated flame retardants may be used in EPS foam (e.g., tetrabromo-cyclooctane , dibromoethyldibromocyclohexane and TBBPA), but a deta iled analysis of their effectiveness in this application when compared with HBCD is not available (Moros e, 2006). There are commercially available

substitutes for XPS and EPS foam board in the construction process that do not use brominated flame retardants. Polyester and polyether polyols, as well as phenolic foam may be used to produce insulation boardstock from rigid foam. Ot her substitutes include alternative insulation types such as blanket, loose-fill, a nd reflective insulation (Morose, 2006).

Several chemicals may be used as alternativ es for HBCD in textile applications. For textile backing, these include deca-BDE, chloroparaffins and ammonium polyphosphate (ECHA, 2009). There are several alternat ives to HBCD for use in high -impact polystyrene (HIPS). Deca-BDE is currently the most widely used flame retardant in HIPS (Weil and Levchik, 2009)

and is also used in electronic wi re insulation. Deca-BDE and chlo roparaffins may not be suitable

for use as substitutes for HBCD due to concerns about their persistent, bioaccumulative and toxic properties. Other chemicals that can be used as alternatives to HBCD in HIPS include both halogenated flame retardants used in conjunction with antimony trioxide (ATO) and organic aryl phosphorus compounds (ECHA, 2009).

V. Hazard Identification Summary

Human Health Effects

HBCD is absorbed via the gastro-intestinal tract and accumulates in the adipose tissue (body fat), muscle and liver in experimental animals (Chengelis, 2001). Bioaccumulation was observed to be higher in female than male ra ts (Chengelis, 2001). Th e elimination of HBCD from body fat is markedly slower than from other tissues with an elimination half-life of weeks to months (Chengelis, 2001). Repeated exposure of HBCD to rats showed disturbances in thyroid hormone system and effects on the thyr oid in males and females (Chengelis, 2001). A study by Eriksson, et al. (2006), conc luded that neonatal exposure of HBCD to mice affected spontaneous motor behavior, learni ng and memory processes in adult mice. However, this study was not conducted according to established OECD 4 test guidelines. In a recently conducted, more robust, two-generation re productive toxicity study in rats conducted according to established test guidelines, HBCD showed treatment-related repr oductive effect (a significant decrease in the number of primordial follicles in the F1 females) (Ema, et al., 2008). Although

this decrease in ovarian follicle s did not affect any reproductive parameters in this study, this effect is suggestive of potenti al reproductive toxicity. Develo pmental effects were observed including delays in eye opening in the second (F2) generation a nd transient changes in learning

4 Organization for Economic Cooperation and Development

Page 3 of 12and memory in F1 males, but exposure did not cause any changes in spontaneous behavior. In addition, there was high and dose-dependent pup mortality during lactation (Ema, et al., 2008).

Environmental Effects

Laboratory studies have shown that HBCD is capable of pr oducing adverse effects in a variety of organisms including algae, fish, invertebrates and soil-dwelling organisms at environmentally relevant concentr ations. HBCD is toxic to al gae and acutely toxic to fish embryos (Desjardins, et al., 2004; Deng, et al., 2009). A number of sub-lethal effects (e.g., altered thyroid status, protein metabolism, oxidativ e stress, reproductive ac tivity) have also been observed in fish (Palace, et al ., 2008; Kling and Förlin, 2009; Zha ng, et al., 2008; Ronisz, et al., 2004). Drottar and Krueger (1998) reported a reduced number and size of daphnid offspring in first and second generations. Thyroid hormone-d ependent developmental effects were observed in tadpoles ( Xenopus laevis ) exposed to HBCD (Schriks, et al., 2006). HBCD has been reported to reduce egg production and lower bi omass in soil dwelling organisms ( Lumbriculus variegatus ) (Oetken, et al., 2001). HBCD administered to chicken ( Gallus domesticus ) embryonic hepatocytes in vitro resulted in significant alterations in expression of genes (mRNA) associated with liver and thyroid function (Crump, et al., 2008). Thinner e gg shells were measured in American kestrels exposed to a combination of PBDEs and HBCD (Fer nie, et al., 2009).

VI. Physical-Chemical Properties a nd Fate Characteriz ation Summary

The members of the HBCD flame retardants category are solids with negligible to low vapor pressure and negligible to low water solu bility. [Molecular Weight = 642; Melting Point = 190 °C (average); Vapor Pressure 6.3 x 10 -5 Pa at 21°C; log K

ow = 5.6 (technical product); and Water Solubility 66 ppb ( μ g/L) (EC 2008).

Persistence

Limited data are available on the degradati on of HBCD in soil, water or sediment. Laboratory studies have shown that HBCD is degraded by abiotic and biotic processes in soil and aquatic sediment with reported half-lives of 2 days to 2 months (Davis, et al., 2005; 2006). These data are consistent with low persistence acc ording to half-life criteria set forth in the PMN program (64 FR 60194, November 4, 1999) and inte rnational Persistent Organic Pollutants (POPs) protocols (UNEP, 2007; Norden, 2008). Ho wever, environmental monitoring data shows frequent occurrence of HBCD in biota over la rge areas and in remote locations where no demonstrable sources have been shown to account for the exposures (see discussion of environmental exposures in Sect ion VII below), supporting the findi ng that HBCD is sufficiently persistent in the environment to be of concern wi thin the scope of these international protocols.

Measured levels of HBCD in dated sediment co re samples also provide evidence of persistence (UNEP, 2007). The frequent de tection of HBCD over a large ge ographic area, with increasing exposure in remote locations such as the Arctic , where no demonstrable lo cal sources exist that can account for these exposures, suggest that H BCD is persistent and undergoes long-range atmospheric transport (UNEP, 2007).

Page 4 of 12Bioaccumulation

HBCD is highly bioaccumulative. Veit h, et al. (1979) reported a measured bioconcentration factor (BCF) of 18,100 for HBCD in fathead minnows, and this value was later confirmed by a kinetic study with rainbow trout (Drottar, et al., 2001), for which the mean BCF was 19,200. A monitoring study by deBoer, et al. (2002) included a wide variety of biota (invertebrates, fish, birds and marine mammals) and showed that HBCD bioaccumulates easilyand biomagnifies in food chains. In a Swedish monitoring study (Sellstrom, et al. 1998), a fishto-sediment ratio of 15 to 1 (expressed as a biot a/sediment accumulation factor or BSAF of 15) was reported for one of two sites, indicating th at HBCD is bioavailable and bioaccumulative. Isomer-specific biomagnification has been demons trated based on monitoring of a Lake Ontario food web (Tomy, et al. 2004). Monitoring in Sw eden found much higher levels of HBCD in eggs from wild peregrine falcons than from captive populations feeding on chickens (Lindberg, et al., 2004) or guillemot from the Baltic Sea (Sel lstrom, et al., 2003), de monstrating that HBCD may also bioaccumulate in terrestrial organisms and food chains.

VII. Exposure Characterization Summary

Releases

HBCD is not reported in the T oxics Release Inventory. No readily available quantitative

release information in the U.S. was found. EC HA reported a total of about 3,100 kg/year of HBCD released to the environment in Europe in 2008, of which 50% were to wastewater, 29% to surface water and 21% to air (ECHA, 2009). Th e overall volume used in 2007 was estimated at 11.6 million kg/year (ECHA, 2009). A Swedish articl e indicates the primary source of release of HBCD in Europe is from textile applications (KEMI, 2006). Based on IUR data, the volume of HBCD used for textile applicati on in the U.S. is estimated to be < 1 % of the total volume of HBCD produced/imported and hence releases from th is use in the U.S. are expected to be relatively small (as a percentage of overall volume produced/imported).

Information from the United Kingdom indicates that the primary sources of HBCD in the environment are from fugitive emissions during its manufacture and use in subsequent products, potentially from leaching in landfills, and from incinerator emissions (UKEA, 2009). As an additive flame retardant, HBCD is not chemically bound to the matrix of the material it protects, and thus has the potential to enter the environmen t from the finished products in use or after disposal (US EPA, 2008b). EC HA states: “A substantial pr oportion of articles containing HBCD will have very long service life (30+ year s for typical insulation like EPS and XPS) and environmental releases will continue for a long ti me into the future.” (ECHA, 2009). It is not known how comparable the releas es of HBCD from manufacturi ng and use operations in the U.S. are to those reported in Europe.

Human Exposure

HBCD is typically manufactured as a pow der of approximately 100 microns in size; however, a portion of the materials is micronize d to 1 micron during manufacture (U.S. Patent 4980382), which poses the potential of deep lung particulate exposure (Rozman, et al., 2001)).

Page 5 of 12Workers who do not wear appropri ate respiratory protection have the high potential for deep lung exposure of the 1 micron material. Particles 1 micron and smaller are able to penetrate to the alveolar sacs of the lungs. They may be absorbed into blood or cleared through the lymphatics. The overall removal of particles from the alveoli is relatively inefficient; on the first day only about 20 percent of particles are clea red, and the portion remaining longer than 24 hours is cleared very slowly. So me particles may remain in the alveoli indefinitely (Rozman, et al., 2001). Commercial workers al so may have potential dermal and inhalation exposure to the chemical during application (EC, 2008). The O ccupational Safety and Health Administration (OSHA) has not established a Permissible Exposur e Limit for HBCD. An occupational exposure study at an industrial plant in Europe producing EPS, reported m easured elevated airborne dust

levels and measured HBCD in the blood of workers (Thomsen, et al., 2007). No readily available HBCD occupational exposure inform ation (including biomonitoring data) was found

for U.S. workers. Based on available IUR re porting, the maximum total number of industrial workers likely to be exposed to this chemical during manufacturing and industrial processing and use is between 100 and 999 (US EPA, 2006); however , this is likely an underestimate since it does not include the commercial workers and some IUR submitters did not have to report numbers of workers because they manufacture belo w the threshold required for reporting or the information was reported to be not readily obtainable.

HBCD has been detected in human adipose tissue, milk, and blood (Covaci, et al, 2006; Johnson-Restrepo, et al, 2008; Arnot , et al., 2009). General population exposure to HBCD is likely from its presence in food (Hiebl and Ve tter, 2007; Fernandes, et al., 2008; van Leeuwen and de Boer, 2008), outdoor air, particularly near poi nt sources (Covaci, et al., 2006), and indoor air (Law, et al., 2008). HBCD has also been det ected in indoor dust (Covaci, et al., 2006; Law, et al., 2008; Roosens, et al., 2009).

The IUR information suggests either that HBCD will not be used in children’s consumer products or that this type of information is not readily available. However, to the extent it is present in household applicati ons (e.g., building foam, furnitur e upholstery, carpeting), children could be exposed, especially given children’s incr eased exposure via dust and the hand-to-mouth ingestion pathway. In vitro experiments conducted to demonstrate leaching of HBCD from textiles showed that the presence of simulated bi ological fluids (sweat, sa liva) and fruit juices enhances the leaching of HBCD from back-c oated samples (Ghanem, 2009). Children’s exposure to HBCD from mouthing of textiles and from ingestion of dust has been estimated (EC, 2008).

Environmental Exposure

HBCD has been measured in air and sediment in Scandinavian countries, North America and Asia (Covaci, et al., 2006, Arnot , et al., 2009). HBCD has been measured in marine and arctic mammals, freshwater and marine fish, aquatic invertebrate s, birds and bird eggs, and one plant species (Covaci, et al., 2006; Arnot, et al., 2009) . HBCD has been detected in Arctic air in

northern Scandinavia and in Arctic birds and bird eggs, Arctic fi sh, ringed seals and polar bears (UNEP, 2009). It has been detected in freshw ater, marine, and avian organisms, and in upper trophic-level mammals (polar bears and seals). The majority of th ese studies are European, some

Page 6 of 12are from North America, and a few are from Asia. A study repor ted decreased levels of HBCD in biota once a United Kingdom manufacturi ng plant was closed (Law, et al., 2008b).

VIII. Risk Management Considerations

HBCD is of international concern because of its PBT properties. HBCD was added to ECHA’s list of Substances of Very High C oncern (SVHCs) on October 28, 2008 (ECHA, 2008). HBCD is under consideration for listing under the POPs Protocol to the Convention on LongRange Transboundary Air Pollution, as technical revi ew has concluded that HBCD is persistent, bioaccumulative, can cause adverse effects to humans or the environment, and has the potential to be transported long distances within the meaning of the Prot ocol (UNECE, 2010). Under the Stockholm Convention for Persistent Organic Po llutants, the POPs Re view Committee decided in October 2009 that Annex D screening cr iteria have been met for HBCD; further determinations have not been made (UNEP, 2010).

HBCD is persistent, bioaccumulative and toxic, especially to aquati c organisms. HBCD biomagnifies in food chains. Given its presence in the environment including wildlife, and the high hazard for HBCD to algae and aquatic invertebrates, EPA has a concern for the potential risk to these aquatic organisms.

EPA has presented evidence which strongly sugg ests there is potential for exposure to the general population from HBCD in the environment, as well as exposure to HBCD from products and dust in the home and workplace. HBCD show s toxicity in repeated-dose (28- and 90-day feeding studies) tests. There may be some huma n health hazard concern based on thyroid effects and indications of developmental and transient ne urobehavioral effects. These health effects combined with potential exposures suggests some concern for a potential risk to the general population from HBCD is warra nted. Greater concern is warranted for workers who manufacture the chemical and produce products that contain it, gi ven available expose

information.

Availability of substitutes for HBCD uses is an unresolved issue, especially for EPS and XPS building foam board applications, where othe r, more suitable flame retardants may not be readily available.

HBCD is currently on the Integrated Risk Information System (IRIS) program agenda. The anticipated date for a completed assessment has not yet been determined. (US EPA, 2010).

HBCD is under consideration for inclusion in the NHANES human bio-monitoring program, which could provide data on exposure in the U.S.

Potential Impacts on Children

HBCD is found in household dust, and it is used in the U.S. in certain consumer products, both of which could represent exposure pathways to children. HBCD has been measured in blood serum and breast milk, so that a developing fe tus or nursing infant could be exposed to it. The reproductive, developmental and neurotoxic h ealth hazards that could result from exposures to HBCD are an important consideration in prot ecting children’s health. These factors suggest

Page 7 of 12that concerns for potential risks to children and pregnant women should be considered with any actions taken to manage this chemical.

IX. Next Steps

In conducting this review of HBCD, EPA considered a number of potential risk management actions, including regulatory acti ons under TSCA sections 4 and 5 and under the Emergency Planning and Community Right-to- Know Act (EPCRA) 313, as well as voluntary actions through such programs as Design for the Environment (DfE).

Based on its screening-level review of h azard and exposure information, EPA intends to initiate actions to protect humans and the environment from exposure to HBCD due to manufacture (including import) use, or disposal of comm ercial HBCD. In addition, as part of the Agency’s efforts to address these chemical substa nces, EPA also intends to evaluate the potential for disproportionate impact of exposure to HBCD on children and other sub-populations.

On the basis of existing information, the Ag ency believes that the following actions

would be warranted:

 Consider initiating ru lemaking under TSCA Section 5(b )(4) of TSCA to add HBCD to the list of chemicals which present or may pres ent an unreasonable risk of injury to health or the environment. EPA intends to publis h a notice of proposed rulemaking by the end

of 2011.

 Initiating rulemaking under TSCA section 5(a )(2) to designate manufacture or processing

of HBCD for use in consumer textiles as a flame retardant as a significant new use which would require manufacturers and processors to notify EPA before manufacturing or processing HBCD for the significant new use. This Significant New Use Rule (SNUR) also would be proposed to apply to imports of consumer textiles articles containing HBCD. EPA has evidence to suggest that th e use of HBCD in textiles may be limited to specialty commercial applications, and that general consumer textile use may be so limited it would be appropriate for SNUR regulation. If information shows this assumption to be incorrect, EPA will consid er initiating rulemaki ng under TSCA section 6(a) to address general consumer textile use.

 Consider initiating ru lemaking under TSCA section 6(a) to regulate HBCD. A section 6(a) action could take the form of a comp rehensive ban on the manufacturing, processing,

distribution in commerce and use of a chemical substance, or a more targeted regulation to address specific activities. The extent of the rule for HBCD would be determined during the rulemaking process.

 Initiating rulemaking in late 2011 to add HBCD to the Toxics Release Inventory. HBCD is currently not listed by any CASRN on th e Emergency Planning and Community Rightto-Know (EPCRA) section 313 list of toxi c substances. Listing will require manufacturers or importers to provide envi ronmental release information not currently captured by IUR.

Page 8 of 12 Conduct a Design for the Environment and Gree n Chemistry alternatives assessment of HBCD. The information developed could be used to encourage i ndustry to move away from HBCD instead of, in addition to, or as part of any regulatory action taken under

TSCA. The alternatives assessment woul d build upon existing knowledge and would consider various exposed populations, includ ing sensitive human subpopulations, as well as environmental exposure. The work will begin in 2011, with completion expected in

2013.

X. References

Arnot, J., McCarty, L., Armitage, J., Toose-Reid, L., Wania, F., and Cousins, I. 2009. An evaluation of hexabromocyclododecane (HBCD) for Persistent Organic Pollutant (POP) properties and the potential for adverse effects in the environment. Submitted to European Bromin ated Flame Retardant Industry Panel (EBFRIP). 26 May

2009.

Chengelis, C. 2001. An oral (gavage) 90 day toxicity study of HBCD in rats. Study No. WIL-186012. WIL Research Laboratories, Inc., Ashland, Ohio.

Covaci, A., Gerecke, A.C., Law, R.J., Voorspoels, S., K ohler, M., Heeb, N.V., Leslie, H., Allchin, C.R., and De Boer, J. 2006. Hexabromocyclododecanes (HBCDs) in the Environment and Humans: A Review. Environ. Sci. Technol. 40, 3679-3688.

Crump, D. ; Chiu, S. ; Egloff, C. ; Kennedy. S.W. 2008. Effects of hexabromocyclododecane and polybrominated diphenyl ethers on mRNA expression in chicken (Gallus dom esticus) hepatocytes. Toxicol. Sci. 2008, 106, 479-487.

Davis JW, S Gonsior, G Marty, J Ariano. 2005. The transformation of hexabromocyclododecane in aerobic and anaerobic soils and aquatic sediments. Water Res. 39:1075-1084.

Davis JW, SJ Gonsior, DA Markham, URS Friederich, RW Hunziker, JM Ariano. 2006. Biodegradation and product identification of [ 14 C]hexabromocyclododecane in wastewater sludge and freshwater sediment. Environ. Sci.

Technol. 40:5395-5401.

DeBoer J.; Allchin, C.; Zegers, B.; Boon, J.P.; Brandsma, S.A.; Morris, S.; Kruijt, A.W.; van der Veen, I.; Hesselingen, J.M.; Haftka, J.J.H.. 2002. HBCD and TBBP-A in sewage sludge, sediments and biota, including interlaboratory study. Ymuiden, The Netherlands: Netherla nds Institute for Fisheries Re search (RIVO) BV. Report

number C033/02.

Deng, J. ; Yu, L, ; Liu, C. ; Yu , K. ; Shi,, X. ; Ye ung, L.W.Y. ; Lam, P.K.S. ; Wu, R.S.S. ;Zhou B. 2009. Hexabromcyclododecane-induced developmen tal toxicity and apoptosis in zebra fish embryos. Aquatic Toxicol. 2009, 93, 29-36.

Desjardins D.; MacGregor, J.A.; Krueger, H.O. 2004. Hexabromocyclododecane (HBCD): A 72-hour toxicity test with the marine diatom (Skeletonema costatum). Final Re port. Wildlife International, Ltd., Easton, Maryland, USA. pp 66.

Drottar KR and Krueger HO. 1998. Hexabromocyclodod ecane (HBCD): An flow-through life-cycle toxicity test with the cladoceran (Daphnia magna). Final report. 439A-108, Wildlife In ternational, Ltd, Easton, Maryland, USA. 1998. 78pp.

Drottar, K.R.; MacGregor, J.A.; Kr ueger, H.O. 2001. Hexa bromocyclododecane (HBCD): An early life-stage toxicity test with the rainbow trout (Oncorhynchus mykiss). Final Report. Wildlife International, Ltd, Easton, Maryland, USA. 2001. pp 1-102.

Page 9 of 12EC 2000. European Commission 2000 IUCLID Dataset for Hexabromocyclododecane [25637-99-4]

EC 2008. European Commission. Risk Assessment: He xabromocyclododecane CAS-No .: 25637-99-4 EINECSNo.: 247-148-4, Final Report May 2008. Office for Official Publications of the European Communities: Luxembourg, 2008.

ECHA 2008. European Chemical s Agency. Decision Number ED /67/2008. October 28, 2008.

ECHA, 2009. European Chemicals Agen cy. Data on Manufacture, Import, Ex port Uses and Releases of HBCDD as

well as Information on Potential Alternativ es to Its Use. December 1, 2009. http://echa.europa.eu/doc/consultations/reco mmen dations/tech_reports/tech_rep_hbcdd.pdf

Em a, M., Fujii, S., Hirata-Koizumi, M., and Matsumoto, K. 2008. Two-generation reproductive toxicity study of the flame retardant hexabromcyclododecane in ra ts. Reproductive Toxi cology, 25:335-351.

Eriksson, P.; Fisher, C.; Wallin, M.; Jakobsson, E.; Fredriksson, A. 2006. Impaired behaviour, learning and memory, in adult mice neonatally exposed to hexabromocyc lododecane (HBCDD). Environ. Toxicol. Pharmacol. 2006, 21, 317-322.

Fernandes, A., Dicks, P., Mortimer, D., Gem, M., Sm ith, F., Driffield, M., White, S., and Rose, M. 2008. Brominated and chlorinated dioxins, PCBs, and brominated flame retardants in Scottish shellfish: methodology, occurrence and human dietary exposure. Mol. Nutr. Food Res. 52, 238-249.

Fernie, K.J. ; Shutt, J.L. ; Letcher, R. J. ; Ritchie, I.J. ; Bird, D.M. 2009. En vironmentally relevant concentrations of DE-71 and HBCD alter eggshell thickness and reproductive success of American kestrels . Environ. Sci. Technol. 2009, 43, 2124-30.

Ghanem, R. 2009. Kinetics of Thermal and Photolytic Segregation of Hexabromocyc lododecane in Backcoated Textile Samples. Jordan J Chem. 4, 171-181.

Guerra, P.,et al.; (2009); Transfer of hexabromocyclododecane from industrial effluents to sediments and biota: Case study in Cinca river (Spain). Journal of Hydrology, 2009, 378, 355.

Heibl, J., and Vetter W. 2007. Detection of hexabromocyclododecane and its metabolite pentabromocyclodedecane in chicken egg and fish from the official food control. J. Agric. Food Chem. 55, 3319-3324.

Johnson-Restrepo, B., Adams, D.H., and Kannan, K. 2008. Tetrabromobisphenol A (TBBPA) and hexabromocyclododecanes (HBCDs) in tissues of humans, dolphins, and sharks from the United States. Chemosphere 2008, 70, 1935-1944.

Kemi 2006. Survey and Technical Assessment of Alte rnatives to TBBPA and HBCDD’, KEMI Swedish Chemicals Agency, Jan 2006 http://www.kemi.se /upload/Trycksaker/Pdf/PM/PM1_06.pdf

Kling, P.; Förlin, L. 2009. Proteomic studies in zebrafis h liver cells exposed to the brominated flame retardants HBCD and dTBBPA. Ecotoxicol. Environ. Saf. 2009, 72, 985-1993.

Law, R.J., Herzke, D., Harrad, S., Morris, S., Bersuder, P., and Allchin, C.R. 2008. Levels and trends of HBCD and BDEs in the European and Asian environments, with some information for other BFRs. Chemosphere 2008, 73,

223-241.

Law, RJ, Bersuder, P., Barry, J., Wilford, B.H., Allchin, C.R. and Jepson, P.D. 2008b. “A Significant Downturn in Levels of Hexabromocyclododecane in the Blubber of Harbor Porpoises (Pho coena phocoena) Stranded or Bycaught in the UK: An Update to 2006 Environ. Sci. Technol. 2008, 42, 9104–9109.

Page 10 of 12Li ndberg, P.; Sellstrom, U.; Haggberg, L.; de Wit, C.A.. 2004. Higher brominated diphenyl ethers and hexabromocyclododecane found in eggs of peregrine falcons (Falco peregrinus) breeding in Sweden. Environ. Sci.

Technol. 38:93-96.

Morose, G. 2006. An Overview of Alternatives to Tetrabromobisphenol A (TBBPA) and Hexabromocyclododecane (HBCD)”. A Publication of the Lowell Center for Sustainable Production University of Massachusetts – Lowell, Lowell, MA. http://www.chemicalspolicy.org/downloa d s/AternativestoTBBPAandHBCD.pdf . (accessed April 1,

2 010).

Norden, 2008. Hexabromocyclododecane as a possible global POP. TemaNord 2008:520. Nordic Council of Ministers, Copenhagen 2007 ISBN 978-92-893-1665-1

Oetken, M.; Ludwichowski, K-U.; Nage l, R. 2001. Validation of the pre liminary EU-concept of assessing the impact of chemicals to organisms in sediment by using selected substances. UBA-FB 299 67 411, Institute of Hydrobiology, Dresden University of Technology, Dresden, Germany. 2001, pp 97.

Palace, V.P.; Pleskach, K.; Halldorson, T.; Danell, R.; Wa utier, K.; Evans, B.; Alaee, M.; Marvin, C.; Tommy, G.T. 2008. Biotransformation enzymes and thyroid axis disruption in juvenile rainbow trout (Oncorhynchus mykiss) exposed to hexabromocyclododecane diastereoisomers. Environ. Sci. Technol. 2008, 42:1967-1972.

Ronisz, D.; Farmen, E.; Finne, E.;, Karlsson, H.; Förlin, L. 2004. Sublet hal effects of the flame retardants hexabromocyclododecane (HBCDD), and tetrabromobisphenol A (TBBPA), on hepatic enzymes and other biomarkers in juvenile rainbow trout and feral eelpout. Aquatic Toxicol. 2004,69, 229-

245.

Roosens, L., Abdallah, M.A. , Harrad, S., Neels, H. and Covaci, A. 2009. Exposure to Hexabromocyclododecanes (HBCDs) via Dust Ingestion, but not Diet, Correlates with Co ncentration in Human Se rum—Preliminary Results. Environ. Health Perspect. doi:10.1289/ehp.0900869. http://dx.doi.org/ . Online 13 July 2009.

Rozm an, K. K.; Klaassen, C. D. Absorption, Distribution, and Excretion of Toxicants. In Casarett and Doull’s Toxicology: The Basic Science of Poisons, 6th edition; Se ils, A.; Noujaim, S. R.; Sheinis, L. A., Eds.; McGrawHill: New York, 2001; pg 117.

Schriks, M. ; Zninavashe, E. ; Furlow, J.D. ; Murk, A. J. 2006. Disruption of thyroid hormone-mediated Zenopus laevis tadpole tail tip regression by hexabromocyclododecane (HBCD) and 2,2’,3,3’,4,4’,5,5’, 6-nona brominated diphenyl ether (BDE206). Chemosphere 2006, 65, 1904-1908.

Sellstrom, U.; Soderstrom, G.; deWit, C.; Tysklind, M. 1998. Photolytic debr omination of decab romodipheny l ether (DeBDE). Organohal. Cmpd 35:447-450.

Sellstrom, U; Bignert, A.; Kierkegaard, A.; Haggberg, L.; de Wit, C.A.; Olsson, M.; Jansson, B.. 2003. Temporal trend studies on tetra- and pentabrominated ethers and hexabromocyclododecane in Guillemot egg from the Baltic

Sea. Environ. Sci. Technol. 37:5496-5501

Thomsen, C.; Molander, P.; Daae, H. L.; Janak, K.; Froshaug, M.; Liane, V. H.; Thorud, S.; Be cher, G.; Dybing, E. 2007. Occupational Exposure to Hexabromocyclododecane At An Industrial Plant. Environ. Sci. Technol. 2007, 41 (15), 5210-5216.

Tomy, G.T.; Budakowski, W.; Halldorso n, T.; Whittle, D.M.; Keir, M.J.; Ma rvin, C.; Macinnis, G.; Alaee, M.. 2004. Biomagnification of α - and γ -hexabromocyclododecane isomers in a Lake Ontario food web. Environ. Sci.

Tehcnol. 38:2298-2303.

UKEA, 2009. United Kingdom Environment Agency. Hexabromocyclododecane in the Environment. http://www.environment-agency.gov.uk/ b usiness/topics/pollution/39137.aspx

Page 11 of 12Page 12 of 12 UNECE, 2010. Economic Commission for Europe. Executive Body for CLRTAP; Report of the Executive Body

on its 27 th Session. ECE/EB.AIR/99. 9 March 2010, p.9 http://www.unece.org/env/document s/2009/ EB/eb/ece. eb.air.99.pdf

UNEP, 2007. Stockholm Convention on Persistent Organic Pollutants. Persistent Organic Pollutants Review Committee, Third meeting, Geneva, 19–23 November 2007, Item 7 of the provisional agenda, Presentation on environmental transport and modeling. The OECD screenin g tool for overall persistenc e and long-range transport potential. UNEP/POPS/POPRC.3/INF/7

UNEP, 2009. Stockholm Convention on Persistent Organic Pollutants. “Summary of the proposal for the listing of hexabromocyclododecane (HBCDD) in Annex A to the Convention.” July 9, 2009. http://chm.pops.int/Convention/POPsReviewCommittee/h rPOPRCMeetings/POPRC5/POPRC5Followupcommunic

ations/HBCDAnnexEInforma tionRequest/tabid/645/langua ge/en-US/Default.aspx

UNEP, 2010. Stockholm Convention on Persistent Organic Pollutants. Invitation to review and provide comments on draft risk profile on hexabromocyclododecane (HBCD). http://chm.pops.int/Convention/POPsReviewCommittee/h rPOPRCMeetings/POPRC5/POPRC5Followupcommunic ations/HBCDInvitationforcommentsondraftRP/tabid/742/language/en-US/Default.aspx (accessed April 24, 2010).

U S EPA. 2006. U.S. Environmental Protection Agency. To xic Substance Control Act (TSCA) Chemical Substance Inventory. 2006 Inventory Update Rule Public Database. Office of Pollution and Prevention of Toxics: Washington, D.C., 2006.

US EPA, 2008. Exposure Characterization for HPV Challenge Chemical, Exposures to the General Population and the Environment, March 14, 2008

US EPA, 2010. Integrated Risk Information System. IRISTrack Report for Hexabromocyclododecane Assessment ( http://cfpub.epa.gov /ncea/iri strac/index.cfm?fuseaction=viewChemical.showChemical&sw_id=1102 ). Accessed

A pril 6, 2010.

US ITC, 2010. US International Trade Commission. Interactive Tariff and Data Web: US Imports for Consumption. http://dataweb.usitc.gov/ (accessed April 1, 2010).

US Patent 4980382 - Process for the preparation of expandable vinyl aromatic polymer particles containing hexabromocyclododecane, http://www.google.com/patents?vid=USPAT4980382

van Leeuwen, S.P., and de Boer, J. 2008. Brominated flame retardants in fish and shellfish – levels and contribution of fish consumption to dietary exposure of Dutch citizens to HBCD. Mol. Nutr. Food Res. 2008, 52, 194-203.

Veith, G.D.; Defoe, D.L.; Bergstedt, B.V.. 1979. Measurin g and estimating the bioconcentration factor in fish. J.

Fish Res. Bd. Can. 36:1040-1048.

Weil E.D.; Levchik, S.V. 2009. Flame Retardants for Plas tics and Textiles Practical Applications. Hanser Gardner Publications. Cincinnati, OH, 2009.

Zhang, X., Yang, F., Zhang, X., Xu, Y., Liao, T., Song, S., Wang J. 2008. Induction of hepatic enzymes and oxidcative stress in Chinese rare minnow (Gobiocypris rarus) exposed to waterborne hexabromocyclododecane (HBCD). Aquatic. Toxicol. 2008, 86, 4-11.